STIP Law Group, LLC
Bioactivity testing structure for single cell tracking using gelling agents
The present invention relates to a novel bioactivity testing structure for single cell tracking using a gelling agent and a bioactivity testing system including the testing structure. The present invention also relates to bioactivity testing, drug susceptibility testing, antibiotic screening, and diagnostic methods using the testing structure. The bioactivity testing structure of the present invention enables very rapid and simple drug susceptibility testing of bacteria, particularly Mycobacterium tuberculosis, drug screening, and bacterial diagnosis. Particularly, the use of the testing structure enables DST and diagnosis of bacteria only by pretreatment without the need to concentrate human sputum samples irrespective of inoculum effect, ensuring rapid, accurate, and simple testing compared to conventional tuberculosis diagnosis or DST systems. In addition, the testing structure of the present invention simultaneously enables the diagnosis and drug susceptibility testing of tuberculosis. Therefore, the present invention provides an effective alternative to the prior art.
QUANTAMATRIX INC.
C G C C C C C C C C C C C C C
C12M G01N C12M C12M C12M C12Q C12M C12M C12M C12Q C12M C12Q C12M C12M C12M
inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Eun Hee Yong-Gyun Hyeon Ju Jung Heon Hyejin Sunghoon Eun Guen Hee jin Haeun Sung Weon Jungil Kyung-Ock
Lee Jung Jeoung Yoo Kim Kwon Kim Kim Kim Ryoo Choi Park